Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/03/2001 | WO2001030849A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |
05/03/2001 | WO2001030848A2 Nucleic acids of the human abc1 gene and applications thereof |
05/03/2001 | WO2001030847A1 Modified gp100 and uses thereof |
05/03/2001 | WO2001030846A1 Beta-defensins |
05/03/2001 | WO2001030845A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
05/03/2001 | WO2001030844A1 Dna encoding human alpha1g-c t-type calcium channel |
05/03/2001 | WO2001030843A1 Ligand activated transcriptional regulator proteins |
05/03/2001 | WO2001030842A1 A new polypeptide-zinc finger protein 36 and the polynucleotide encoding it |
05/03/2001 | WO2001030841A1 A new polypeptide-zinc finger protein 60 and the polynucleotide encoding it |
05/03/2001 | WO2001030840A1 A new polypeptide-zinc finger protein 57 and the polynucleotide encoding it |
05/03/2001 | WO2001030839A1 A novel polypeptide-human rna-binding protein 33 and a polynucleotide encoding the same |
05/03/2001 | WO2001030838A1 A novel polypeptide - gtp-binding protein 17 and a polynucleotide encoding the same |
05/03/2001 | WO2001030837A1 A novel polypeptide - human galectin 15 and a polynucleotide encoding the same |
05/03/2001 | WO2001030835A1 A novel polypeptide - human pogo transposase 14 and a polynucleotide encoding the same |
05/03/2001 | WO2001030834A1 A new polypeptide-zinc finger protein 33 and the polynucleotide encoding it |
05/03/2001 | WO2001030833A1 A new polypeptide - new cell cycle-regulating protein 53 and a polynucleotide encoding the same |
05/03/2001 | WO2001030832A1 A new polypeptide-zinc finger protein hkznf-23 and the polynucleotide encoding it |
05/03/2001 | WO2001030831A1 Secreted proteins and uses thereof |
05/03/2001 | WO2001030829A1 A novel human metabotropic glutamate receptor |
05/03/2001 | WO2001030828A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
05/03/2001 | WO2001030827A1 A novel polypeptide-zinc finger protein 56 and polynucleotide encoding said polypeptide |
05/03/2001 | WO2001030826A1 A novel polypeptide-serine/threonine kinase 29 and polynucleotide encoding said polypeptide |
05/03/2001 | WO2001030821A1 A novel polypeptide-homo rna cyclase 41 and polynucleotide encoding said polypeptide |
05/03/2001 | WO2001030820A1 A novel polypeptide-zinc finger protein 54 and polynucleotide encoding said polypeptide |
05/03/2001 | WO2001030818A1 A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide |
05/03/2001 | WO2001030817A1 Immunogenic proteins from the domestic mite, blomia tropicalis |
05/03/2001 | WO2001030816A1 NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
05/03/2001 | WO2001030815A1 Redox reversible hcv proteins with native-like conformation |
05/03/2001 | WO2001030812A2 Activation of hcv-specific t cells |
05/03/2001 | WO2001030801A1 Antisense modulation of integrin-linked kinase expression |
05/03/2001 | WO2001030800A1 Antisense modulation of y-box binding protein 1 expression |
05/03/2001 | WO2001030798A1 Transgenic mice containing trp gene disruptions |
05/03/2001 | WO2001030797A1 Antisense modulation of methionine aminopeptidase 2 expression |
05/03/2001 | WO2001030489A2 Device and method for hybridizing double-stranded dna samples on oligomer arrays |
05/03/2001 | WO2001030395A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
05/03/2001 | WO2001030394A1 Treatment of cancer |
05/03/2001 | WO2001030393A2 Methods for reducing the effects of cancers that express a33 antigen using a33 antigen specific immunoglobulin products |
05/03/2001 | WO2001030392A2 Delivery of proteins across polar epithelial cell layers |
05/03/2001 | WO2001030385A1 Adjuvants for nucleic acid vaccines |
05/03/2001 | WO2001030384A1 Vaccine compositions |
05/03/2001 | WO2001030382A1 Method of inducing and/or enhancing an immune response to tumor antigens |
05/03/2001 | WO2001030381A2 Use of csf-1 inhibitors |
05/03/2001 | WO2001030362A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
05/03/2001 | WO2001030361A1 Antisense modulation of cytohesin-2expression |
05/03/2001 | WO2001030360A1 Modulation of l-selectin shedding via inhibition of tumor necrosis factor alpha converting enzyme (tace) |
05/03/2001 | WO2001030137A1 N-calcium channel knockout animal |
05/03/2001 | WO2001030133A1 Method for producing a bank or collection of mutants and applications thereof |
05/03/2001 | WO2001014530A3 Method for growing stem cells |
05/03/2001 | WO2001012840A3 Anti-epha2 antibodies as a cancer diagnostic |
05/03/2001 | WO2001007452A8 Extraction of nucleic acids |
05/03/2001 | WO2001005968A9 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
05/03/2001 | WO2001002553A3 Dna binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression |
05/03/2001 | WO2001002541A3 Compositions and methods for regulating abscisic acid-induced closure of plant stomata |
05/03/2001 | WO2001000666A3 Self-aligning peptides derived from human elastin and other fibrous proteins |
05/03/2001 | WO2000078957A3 Scorpion toxins from buthotus judaicus |
05/03/2001 | WO2000078946A3 Treatment of viral influenza with antisense oligonucleotides |
05/03/2001 | WO2000078802A3 Secreted polypeptides and corresponding polynucleotides |
05/03/2001 | WO2000077214A3 Characterization of the yeast transcriptome |
05/03/2001 | WO2000077168A3 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
05/03/2001 | WO2000075332A3 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS |
05/03/2001 | WO2000075320A3 Human genes and proteins encoded thereby |
05/03/2001 | WO2000073431A3 Methods and compositions for measuring ion channel conductance |
05/03/2001 | WO2000072876A3 Prevention and treatment of amyloidogenic disease |
05/03/2001 | WO2000071165A3 Use of chimeric mutational vectors to change endogenous sequences in solid tissues |
05/03/2001 | WO2000071096A3 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
05/03/2001 | WO2000068390A3 Plant recombination proteins |
05/03/2001 | WO2000066789A3 Polynucleotide matrix-based method of identifying microorganisms |
05/03/2001 | WO2000063245A3 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
05/03/2001 | WO2000057180A8 Use of lna in mass spectrometry |
05/03/2001 | WO2000039301A3 Methods for using mycobacterium tuberculosis molecules as immunological adjuvants |
05/03/2001 | WO1995030744A3 Lipases with improved surfactant resistance |
05/03/2001 | DE19952501A1 New nucleic acid encoding L-pantolactone hydrolase, useful for producing pure D-pantolactone, an intermediate for vitamins, from its racemate |
05/03/2001 | DE19951975A1 Neue für das poxB-Gen codierende Nuleotidsequenzen New gene coding for the poxB Nuleotidsequenzen |
05/03/2001 | DE19951768A1 Mikrobiologisches Verfahren zur Herstellung aromatischer Aldehyde und/oder Carbonsäuren A microbiological process for the production of aromatic aldehydes and / or carboxylic acids |
05/03/2001 | DE19951765A1 Wirts-Vektor-Systeme zur Überproduktion von thermolabilen Enzymen psychrophiler Organismen Host-vector systems for overproduction of thermolabile enzymes psychrophilic organisms |
05/03/2001 | DE19951708A1 Für den Export verzweigtkettiger Aminosäuren kodierende Nikleotidsequenzen, Verfahren zu deren Isolierung und ihre Verwendung Coding for the Export of branched-chain amino acids Nikleotidsequenzen, processes for their isolation and their use |
05/03/2001 | DE19951694A1 Regulating expression of transgenes, in vitro or in vivo, useful in, e.g. gene therapy of multiple sclerosis comprises expression of activating or inhibitory ligands |
05/03/2001 | DE19951189A1 Verfahren zur Unterscheidung von 5-Position Methylierungsänderungen von Cytosin-Basen und Cytosin-zu-Thymin Mutationen und zum Nachweis von single nucleotide polymorphisms (SNPs) oder Punktmutation in genomischer DNA Method for distinguishing 5-position methylation changes of cytosine bases and cytosine-to-thymine mutations and for the detection of single nucleotide polymorphisms (SNPs) or point mutation in genomic DNA |
05/03/2001 | DE19949595A1 CTAGE-Genfamilie CTAGE gene family |
05/03/2001 | DE19949179A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid |
05/03/2001 | DE19948408A1 Neue immobilisierbare Amylosucrase und dessen Verwendung sowie Verfahren zur Herstellung von Poly(1,4-alpha-glucan) New immobilizable amylosucrase and the use thereof and processes for the preparation of poly (1,4-alpha-glucan) |
05/03/2001 | DE10039856A1 Inducing cell replication in resting cells, useful for producing cells for e.g. toxicology testing, by transient expression of immortalizing gene |
05/03/2001 | CA2721011A1 Modified gp100 and uses thereof |
05/03/2001 | CA2407652A1 Device and method for hybridizing double-stranded dna samples on oligomer arrays |
05/03/2001 | CA2404438A1 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases |
05/03/2001 | CA2391820A1 Umlr polypeptides |
05/03/2001 | CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
05/03/2001 | CA2389321A1 Neisserial antigenic peptides |
05/03/2001 | CA2389256A1 Beta-defensins |
05/03/2001 | CA2389217A1 Mammalian-type glycosylation in plants |
05/03/2001 | CA2389187A1 Method for producing a bank or collection of mutants and applications thereof |
05/03/2001 | CA2389138A1 Microbiological method for producing aromatic aldehydes and/or carboxylic acids |
05/03/2001 | CA2389127A1 Human sphingosine kinase gene |
05/03/2001 | CA2389117A1 Methods and compositions for enhancing developmental potential of oocytes and zygotes |
05/03/2001 | CA2389113A1 Plants with a modified flower and seed development |
05/03/2001 | CA2389110A1 Regulation of gene expression by neuroleptic agents |
05/03/2001 | CA2389084A1 Process for modifying plants |
05/03/2001 | CA2389031A1 Dna encoding human alpha1g-c t-type calcium channel |
05/03/2001 | CA2388998A1 Treatment of cancer |
05/03/2001 | CA2388950A1 Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application |